GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$72.00
Tradestie Score
61
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
-8.3%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$18.42
|
$4.60B | 42.8 | 57 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$65.64
|
$3.26B | - | 56 | Compare |
|
VCYT
Veracyte, Inc.
|
$56.97
|
$2.85B | 52.0 | 60 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.06
|
$2.22B | - | 60 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$90.64
|
$1.77B | - | 59 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$53.36
|
$1.50B | - | 57 | Compare |
|
NEOG
Neogen Corp
|
$9.62
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.35
|
$1.23B | - | 54 | Compare |
|
NEO
NeoGenomics, Inc.
|
$14.11
|
$1.13B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$28.51
|
$798.40M | - | 58 | Compare |
More GRAL Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry